Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Hum Nutr Clin Nutr ; 37(5): 391-4, 1983 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6654698

RESUMEN

Thirty-two patients routinely admitted for cholecystectomy were allocated randomly to receive a post-operative fluid regimen containing either 18 g/d of sodium DL-3-hydroxybutyrate, or isoenergetic glucose, each for 3 d. The difference in the post-operative mean daily urinary nitrogen excretion between the control (median 8.3 g/d) and the 3-OH-butyrate groups (median 8.3 g/d) was not statistically significant, nor was there any difference when allowances were made for patient's surface area or for changes in blood urea during the course of the study.


Asunto(s)
Colecistectomía , Hidroxibutiratos/administración & dosificación , Nitrógeno/metabolismo , Periodo Posoperatorio , Procedimientos Quirúrgicos Operativos , Adulto , Femenino , Glucosa/administración & dosificación , Humanos , Infusiones Parenterales , Masculino , Persona de Mediana Edad , Nitrógeno/orina
2.
Lancet ; 1(8314-5): 15-7, 1983 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-6129367

RESUMEN

Sodium DL-3-hydroxybutyrate was administered to obese subjects (more than 150% ideal body-weight) who were either receiving a 2 . 5 MJ (600 kcal) diet containing 34 g protein on one day with a total fast (water and vitamins only) on the next day, for 21 days, or were undergoing therapeutic starvation for 14 days. Both intravenous and oral hydroxybutyrate significantly reduced net body protein loss as measured by total urinary nitrogen and 3-methylhistidine excretion. Hydroxybutyrate administration did not significantly affect the rate of weight-loss but seemed to increase the fat/lean ratio of the tissue loss. The subjects experienced no untoward effects and none complained of hunger while receiving 3-hydroxybutyrate.


Asunto(s)
Dieta Reductora/métodos , Ayuno , Hambre/efectos de los fármacos , Hidroxibutiratos/uso terapéutico , Obesidad/dietoterapia , Ácido 3-Hidroxibutírico , Administración Oral , Adulto , Peso Corporal/efectos de los fármacos , Encéfalo/metabolismo , Femenino , Humanos , Hidroxibutiratos/metabolismo , Hidroxibutiratos/farmacología , Inyecciones Intravenosas , Cuerpos Cetónicos/metabolismo , Masculino , Persona de Mediana Edad , Nitrógeno/orina , Obesidad/tratamiento farmacológico
16.
Proc Nutr Soc ; 29(1): Suppl:10A+, 1970 May.
Artículo en Inglés | MEDLINE | ID: mdl-5476566
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA